# Day `r Day` Univariate CoR: Cox Models of Risk {#cor-coxph-Day`r Day`}

The main regression model is the Cox proportional hazards model. All plots are made with Cox models fit unless specified otherwise.

## Hazard ratios

\begin{table}[H]
\caption{Inference for Day `r Day` antibody marker covariate-adjusted correlates of risk of COVID in the vaccine group: Hazard ratios per 10-fold increment in the marker*}
\begin{center}
    \input{`r pathCoRoutput`/CoR_univariable_svycoxph_pretty_`r study_name`}\\
\end{center}
*Baseline covariates adjusted for: baseline risk score, at risk or not, community of color or not. Maximum failure event time \input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} days.\\
**No. at-risk = number of per-protocol baseline negative vaccine recipients at-risk for COVID; no. cases = number of this cohort with an observed COVID endpoints starting 7 days post Day `r Day` visit.

    %\label{tab:CoR_univariable_svycoxph_pretty_`r study_name`}
\end{table}


\begin{table}[H]
\caption{Inference for Day `r Day` antibody marker covariate-adjusted correlates of risk of COVID in the vaccine group: Hazard ratios for Middle vs. Upper tertile vs. Lower tertile*}
\begin{center}
\setlength{\tabcolsep}{.5ex}
\input{`r pathCoRoutput`/CoR_univariable_svycoxph_cat_pretty_`r study_name`}\\
\end{center}
*Baseline covariates adjusted for: baseline risk score, at risk or not, community of color or not. 
Maximum failure event time \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} days.
Cutpoints:
%Day `r Day` cutpoints:
\input{`r pathCoRoutput`/cutpoints_Day`r Day`bindSpike_`r study_name`},  
\input{`r pathCoRoutput`/cutpoints_Day`r Day`bindRBD_`r study_name`},  
\input{`r pathCoRoutput`/cutpoints_Day`r Day`pseudoneutid50_`r study_name`},  
\input{`r pathCoRoutput`/cutpoints_Day`r Day`pseudoneutid80_`r study_name`}.
%fold-rise cutpoints:
%\input{`r pathCoRoutput`/cutpoints_Delta`r Day`overBbindSpike_`r study_name`},  
%\input{`r pathCoRoutput`/cutpoints_Delta`r Day`overBbindRBD_`r study_name`},  
%\input{`r pathCoRoutput`/cutpoints_Delta`r Day`overBpseudoneutid50_`r study_name`},  
%\input{`r pathCoRoutput`/cutpoints_Delta`r Day`overBpseudoneutid80_`r study_name`}.  
\\
**No. at-risk = number of per-protocol baseline negative vaccine recipients at-risk for COVID at 7 days post Day `r Day` visit; no. cases = number of this cohort with an observed COVID endpoints.\\
***Generalized Wald-test p-value of the null hypothesis that the hazard rate is constant across the Lower, Middle, and Upper tertile groups.
    %\label{tab:CoR_univariable_svycoxph_cat_pretty_`r study_name`}
\end{table}
\begin{figure}[H]
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/hr_forest_bindSpike_`r study_name`}
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/hr_forest_bindRBD_`r study_name`}
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/hr_forest_pseudoneutid50_`r study_name`}
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/hr_forest_pseudoneutid80_`r study_name`}
    \caption{Forest plots of hazard ratios per 10-fold increase in the marker among baseline seronegative vaccine recipients and subgroups with 95\% point-wise confidence intervals.}
\end{figure}
\clearpage
\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/hr_forest_marginal_bindSpike_`r study_name`}
    \caption{Forest plots of hazard ratios per 10-fold increase in the Day `r Day` binding Ab to spike markers among baseline seronegative vaccine recipients (top row) and eight subpopulations (row 2-9) with 95\% point-wise confidence intervals.}
\end{figure}
\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/hr_forest_marginal_bindRBD_`r study_name`}
    \caption{Forest plots of hazard ratios per 10-fold increase in the  Day `r Day` binding Ab to RBD markers among baseline seronegative vaccine recipients (top row) and eight subpopulations (row 2-9) with 95\% point-wise confidence intervals.}
\end{figure}
\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/hr_forest_marginal_pseudoneutid50_`r study_name`}
    \caption{Forest plots of hazard ratios per 10-fold increase in the  Day `r Day` pseudo neut ID50 markers among baseline seronegative vaccine recipients (top row) and eight subpopulations (row 2-9) with 95\% point-wise confidence intervals.}
\end{figure}
<!-- \begin{figure}[H] -->
<!--     \centering -->
<!--     \includegraphics[width=1\textwidth]{`r pathCoRoutput`/hr_forest_marginal_liveneutmn50_`r study_name`} -->
<!--     \caption{Forest plots of hazard ratios per 10-fold increase in the  Day `r Day` live neut MN50 markers among baseline seronegative vaccine recipients (top row) and eight subpopulations (row 2-9) with 95\% point-wise confidence intervals.} -->
<!-- \end{figure} -->
\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/hr_forest_marginal_pseudoneutid80_`r study_name`}
    \caption{Forest plots of hazard ratios per 10-fold increase in the  Day `r Day` pseudo neut ID80 markers among baseline seronegative vaccine recipients (top row) and eight subpopulations (row 2-9) with 95\% point-wise confidence intervals.}
\end{figure}
\clearpage
<!-- \begin{table}[H] -->
<!--     \setlength{\tabcolsep}{.5ex} -->
<!-- \scriptsize{ -->
<!--     \input{`r pathCoRoutput`/CoR_univariable_svycoxph_`r study_name`} -->
<!-- } -->
<!-- \caption{CoR models among baseline seronegative vaccine recipients. Each column corresponds to one Cox model fitted by survey::svycoxph.} -->
<!--     \label{tab:CoR_univariable_svycoxph_`r study_name`} -->
<!-- \end{table} -->
<!-- \begin{table}[H] -->
<!--     \setlength{\tabcolsep}{.5ex} -->
<!--     \input{`r pathCoRoutput`/CoR_pseudoneutid80_sens_noCases_`r study_name`} -->
<!-- \caption{CoR models for Day `r Day` pseudo neut ID80 among baseline seronegative vaccine recipients. Each row corresponds to one Cox model fitted by survey::svycoxph.For each model, a different dataset that keeps a random subset of the cases is used. The original dataset has 66 cases.} -->
<!--     \label{tab:CoR_Day`r Day`pseudoneutid80_sens_noCases_`r study_name`} -->
<!-- \end{table} -->
<!-- \begin{table}[H] -->
<!--     \setlength{\tabcolsep}{.5ex} -->
<!--     \input{`r pathCoRoutput`/CoR_pseudoneutid80_5cases_`r study_name`} -->
<!-- \caption{CoR models for Day `r Day` pseudo neut ID80 among baseline seronegative vaccine recipients. Each row corresponds to one Cox model fitted by survey::svycoxph.For each model, a different dataset that keeps a random subset of 5 cases is used.} -->
<!--     \label{tab:CoR_Day`r Day`pseudoneutid80_5cases_`r study_name`} -->
<!-- \end{table} -->
<!-- \begin{table}[H] -->
<!--     \input{`r pathCoRoutput`/CoR_univariable_tps} -->
<!--     \caption{CoR models among baseline seronegative vaccine recipients. Each column corresponds to one logistic regression model fitted by osDesign::tps. } -->
<!--     \label{tab:CoR_univariable_tps} -->
<!-- \end{table} -->
<!-- \begin{table}[H] -->
<!--     \input{`r pathCoRoutput`/CoR_univariable_hingelogistic} -->
<!--     \caption{CoR models among baseline seronegative vaccine recipients. Each column corresponds to one logistic regression model with hinge fitted by chgnpt::chngptm. } -->
<!--     \label{tab:CoR_univariable_hingelogistic} -->
<!-- \end{table} -->
## Marginalized risk and controlled vaccine efficacy plots
<!-- \begin{figure}[H] -->
<!--     \centering -->
<!--     \includegraphics[width=1\textwidth]{`r pathCoRoutput`/marginalized_risks1_woplacebo_`r study_name`} -->
<!--     \caption{Marginalized cumulative risk by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} as functions of Day `r Day` markers (=s) among baseline seronegative vaccine recipients with 95\% bootstrap point-wise confidence bands. The horizontal lines indicate the overall cumulative risk of the vaccine arm by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} and its 95\% point-wise confidence interval. Histograms of the immunological markers in the vaccine arm are overlaid.} -->
<!-- \end{figure} -->

\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/marginalized_risks1_`r study_name`}
    \caption{Marginalized cumulative risk by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} as functions of Day `r Day` markers (=s) among baseline seronegative vaccine recipients with 95\% bootstrap point-wise confidence bands. The horizontal lines indicate the overall cumulative risk of the placebo and vaccine arms by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} and its 95\% point-wise confidence interval. Histograms of the immunological markers in the vaccine arm are overlaid. lod = `r round(llods["bindSpike"],1)`, `r round(llods["bindRBD"],1)`, `r round(llods["pseudoneutid50"],1)`, `r round(llods["pseudoneutid80"],1)` for bAb Spike, bAb RBD, PsV nAb ID50, PsV nAb ID80, respectively.}
    
\end{figure}

\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/marginalized_risks1_woplacebo_`r study_name`}
    \caption{Marginalized cumulative risk by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} as functions of Day `r Day` markers (=s) among baseline seronegative vaccine recipients with 95\% bootstrap point-wise confidence bands. The horizontal lines indicate the overall cumulative risk of the placebo and vaccine arms by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} and its 95\% point-wise confidence interval. Histograms of the immunological markers in the vaccine arm are overlaid. lod = `r round(llods["bindSpike"],1)`, `r round(llods["bindRBD"],1)`, `r round(llods["pseudoneutid50"],1)`, `r round(llods["pseudoneutid80"],1)` for bAb Spike, bAb RBD, PsV nAb ID50, PsV nAb ID80, respectively.}
\end{figure}

\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/controlled_ve_curves1_`r study_name`}
    \caption{Controlled VE with sensitivity analysis as functions of Day `r Day` markers (=s) among baseline seronegative vaccine recipients with 95\% bootstrap point-wise confidence bands. Histograms of the immunological markers in the vaccine arm are overlaid. lod = `r round(llods["bindSpike"],1)`, `r round(llods["bindRBD"],1)`, `r round(llods["pseudoneutid50"],1)`, `r round(llods["pseudoneutid80"],1)` for bAb Spike, bAb RBD, PsV nAb ID50, PsV nAb ID80, respectively.}
\end{figure}

\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/marginalized_risks2_woplacebo_`r study_name`}
    \caption{Marginalized cumulative risk by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} as functions of Day `r Day` markers above a threshold ($\geq s$) among baseline seronegative vaccine recipients with 95\% bootstrap point-wise confidence bands (at least 5 cases are required). The horizontal lines indicate the overall cumulative risk of the vaccine arm by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} and its 95\% point-wise confidence interval. Histograms of the immunological markers in the vaccine arm are overlaid. lod = `r round(llods["bindSpike"],1)`, `r round(llods["bindRBD"],1)`, `r round(llods["pseudoneutid50"],1)`, `r round(llods["pseudoneutid80"],1)` for bAb Spike, bAb RBD, PsV nAb ID50, PsV nAb ID80, respectively.}
\end{figure}

\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/controlled_ve_curves2_`r study_name`}
    \caption{Controlled VE as functions of Day `r Day` markers (>=s) among baseline seronegative vaccine recipients with 95\% bootstrap point-wise confidence bands. Histograms of the immunological markers in the vaccine arm are overlaid. lod = `r round(llods["bindSpike"],1)`, `r round(llods["bindRBD"],1)`, `r round(llods["pseudoneutid50"],1)`, `r round(llods["pseudoneutid80"],1)` for bAb Spike, bAb RBD, PsV nAb ID50, PsV nAb ID80, respectively.}
\end{figure}

<!-- \begin{figure}[H] -->
<!--     \centering -->
<!--     \includegraphics[width=1\textwidth]{`r pathCoRoutput`/marginalized_risks2_`r study_name`} -->
<!--     \caption{Marginalized cumulative risk by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} as functions of Day `r Day` markers above a threshold (>=s) among baseline seronegative vaccine recipients with 95\% bootstrap point-wise confidence bands (at least 5 cases are required). The horizontal lines indicate the overall cumulative risk of the placebo and vaccine arms by Day \protect\input{`r pathCoRoutput`/timepoints_cum_risk_`r study_name`} and its 95\% point-wise confidence interval. Histograms of the immunological markers in the vaccine arm are overlaid.} -->
<!-- \end{figure} -->
\begin{figure}[H]
    \centering
    \includegraphics[width=1\textwidth]{`r pathCoRoutput`/marginalized_risks_cat_`r study_name`}
    \caption{Marginalized cumulative incidence rate curves for trichotomized Day `r Day` markers among baseline seronegative vaccine recipients. The gray line is the overall cumulative incidence rate curve in the placebo arm.}
\end{figure}